Study of Proteomic Factors in Patients With Severe Dry Eye Syndrome Treated With Autologous Serum Eye Drops.

Abroad (travel likely)Recruiting

Conditions

Dry Eye Syndrome (DES) · Dry Eye

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

CHU de Saint-Etienne, Saint-Etienne, France
Contact: Principal Investigator (Elodie JACQUEROUX, MD)
Freddy MOUNSEF, MD (Sub-investigator)
Marie-Caroline TRONE, MD (Sub-investigator)
Raphaël AUGER, MD (Sub-investigator)
Emera CHHUY, MD (Sub-investigator)

Study leads

Elodie JACQUEROUX, MD
Principal Investigator
CHU de Saint-Etienne

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Multicenter, Open-Label Study to Evaluate Perioperative Treatment of Dry Eye With Miebo® in Subjects Undergoing LASIK

Dry Eye Syndrome (DES) · Dry Eye Disease (DED)

Abroad (travel likely)RecruitingPHASE4

Bozeman, United States · Omaha, United States

Evaluation of a Novel Ocular Lubricating Eye Drop

Dry Eye Syndrome (DES)

Abroad (travel likely)Recruiting

Waterloo, Canada

Laser Acupuncture on Dry Eye and Sjögren's Syndrome-related Dry Eye Symptoms (LADESJS)

Dry Eye Syndrome (DES) · Laser Acupuncture · Sjögren's Syndrome (SS)

Abroad (travel likely)RecruitingPHASE2

Taipei, Taiwan

Exosomes Proteomic for Sjogren's Syndrome and Dry Eye Syndrome

Dry Eye Syndrome (DES) · Sjogren's Syndrome · Xerophthalmia

Abroad (travel likely)Recruiting

Taipei, Taiwan